Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Other Working Capital Changes: 2013-2024

Historic Other Working Capital Changes for Astria Therapeutics (ATXS) over the last 12 years, with Dec 2024 value amounting to $1.3 million.

  • Astria Therapeutics' Other Working Capital Changes rose 984.21% to $618,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.3 million, marking a year-over-year increase of 628.25%. This contributed to the annual value of $1.3 million for FY2024, which is 72.46% down from last year.
  • Latest data reveals that Astria Therapeutics reported Other Working Capital Changes of $1.3 million as of FY2024, which was down 72.46% from $4.5 million recorded in FY2023.
  • In the past 5 years, Astria Therapeutics' Other Working Capital Changes registered a high of $4.5 million during FY2023, and its lowest value of -$1.3 million during FY2020.
  • Its 3-year average for Other Working Capital Changes is $2.5 million, with a median of $1.6 million in 2022.
  • In the last 5 years, Astria Therapeutics' Other Working Capital Changes crashed by 197.52% in 2020 and then soared by 1,944.71% in 2022.
  • Yearly analysis of 5 years shows Astria Therapeutics' Other Working Capital Changes stood at -$1.3 million in 2020, then skyrocketed by 93.24% to -$85,000 in 2021, then soared by 1,944.71% to $1.6 million in 2022, then soared by 189.92% to $4.5 million in 2023, then slumped by 72.46% to $1.3 million in 2024.